The U.S. pays about three times more than other nations for drugs, and Trump's wide-reaching executive order directs pharmaceutical companies to charge similar prices in the U.S. and Europe. The order says its health department will establish a mechanism for patients to buy more drugs directly from manufacturers.

The president rolled out a plan that was less aggressive than his first-term effort in 2020, surprising analysts who were bracing for something tougher.